BRAFV600E基因联合Tg-Ab水平与PTC临床病理特征的相关性分析

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
谭博文,张雪云
文章摘要
本文系统综述了BRAFV600E与TgAb的独立及联合作用与PTC临床病理特征的相关性,并探讨其临床价值。BRAFV600E是PTC中最常见的驱动突变,通过持续激活MAPK/ERK通路促进肿瘤侵袭性。研究表明,BRAFV600E突变与PTC多灶性、淋巴结转移、甲状腺被膜侵犯及复发风险显著相关。TgAb作为甲状腺自身免疫标志物,其水平升高与慢性炎症微环境相关,可独立预测淋巴结转移及肿瘤多灶性。BRAFV600E与TgAb分别从驱动突变和免疫微环境角度反映PTC的生物学行为,联合分析可更全面评估肿瘤侵袭性及预后,为精准诊疗提供依据。
文章关键词
甲状腺乳头状癌;BRAFV600E基因突变;Tg-Ab;临床病理特征;淋巴结转移
参考文献
[1] CHEN B,ZHANG Z,WANG K,等.Association of BRAFV600E mutation with ultrasonographic features and clinicopathologic characteristics of papillary thyroid microcarcinoma:A retrospective study of 116 cases[J/OL].Clinical Hemorheology and Microcirculation, 2019,73(4):545-552. [2] LAI Y,GU Y,YU M,等.Thyroglobulin Antibody(TgAb)Positive is an Independent Risk Factor for Lymph Node Metastasis in Patients with Differentiated Thyroid Carcinoma[J/OL].International Journal of General Medicine,2023,16:5979-5988. [3] XING M,ALZAHRANI A S,CARSON K A,等.Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer[J/OL].JAMA,2013,309(14):1493-1501. [4] LI Y,WANG Y,LI L,等.The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas[J/OL].Scientific Reports,2022,12(1):12674. [5] SPENCER C,FATEMI S.Thyroglobulin antibody(TgAb)methods-Strengths,pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer[J/OL].Best Practice&Research.Clinical Endocrinology&Metabolism,2013,27(5):701-712. [6] LI W,MING H,SUN D,等.The relationship between BRAFV600E,NF-κB and TgAb expression in papillary thyroid carcinoma[J/OL]. Pathology,Research and Practice,2017,213(3):183-188. [7] HUANG D M,ZHI J T,ZHANG J M,等.[Correlations of serum TgAb and TPOAb and clinicopathological features of PTC in children and adolescents][J/OL].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi=Chinese Journal of Otorhinolaryngology Head and Neck Surgery,2022,57(12):1418-1425. [8] SUN D,ZHENG X,HE X,等.Prognostic value and dynamics of antithyroglobulin antibodies for differentiated thyroid carcinoma[J/OL]. Biomarkers in Medicine,2020,14(18):1683-1692. [9] GALÁN-GARCÍA M E,MARTÍNEZ-MARTIN M S,ARAUJO-RUANO E J,等.Thyroid Fine Needle Aspiration,the Bethesda System,and the BRAFV600E Mutation in Papillary Thyroid Carcinoma:Association and Prediction for Biopsy[J/OL].Acta Cytologica, 2023,67(4):346-356. [10] ZHANG J,FENG Y,HE X,等.[Correlation between conventional ultrasound features and BRAFV600E gene mutation and central lymph node metastasis in thyroid papillary carcinoma][J/OL].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi=Journal of Clinical Otorhinolaryngology Head and Neck Surgery,2022,36(3):184-188.
Full Text:
DOI